Publications of the Week

Human TMPRSS2 is a type II transmembrane serine protease and an essential host factor for…

Gene fusions generated by chromosomal rearrangements function as oncogenic drivers in human cancers. We previously…

Androgen receptor (AR) is a therapeutic target for prostate cancer. Despite effectively targeting its folded…

Breast cancer can develop over a wide age range and tumors in younger women differ…

Androgen deprivation therapy is the primary treatment for advanced prostate tumors. While initially effective, tumor…

Despite a wealth of knowledge on the mechanisms underlying craniofacial morphogenesis during gestation, the roles…

Early-life infections can exert profound and lasting effects on brain development and function, potentially through…

The dentate gyrus (DG) of the hippocampus contains a heterogeneous population of granule cells, being…

Fibroblast growth factor receptor (FGFR) alterations are targetable in metastatic urothelial carcinoma (mUC). Identifying FGFR…

Low-grade, stage Ta (TaLG) non–muscle-invasive bladder cancer (NMIBC) is generally nonaggressive; yet, some patients experience…